Jafron Biomedical (China) Analysis

Jafron Stock Analysis Notes

About 51.0% of the company shares are owned by insiders or employees . The company last dividend was issued on the 31st of May 2024. Jafron Biomedical had 1.9:1 split on the 20th of May 2020. For more info on Jafron Biomedical Co please contact the company at 86 75 6368 9708 or go to https://www.jafroninternational.com.

Jafron Biomedical Investment Alerts

Jafron Biomedical Thematic Classifications

Jafron Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 24.34 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Jafron Biomedical's market, we take the total number of its shares issued and multiply it by Jafron Biomedical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Jafron Profitablity

The company has Profit Margin (PM) of 0.31 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.42 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.42.

Management Efficiency

Jafron Biomedical has return on total asset (ROA) of 0.1052 % which means that it generated a profit of $0.1052 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2476 %, meaning that it generated $0.2476 on every $100 dollars invested by stockholders. Jafron Biomedical's management efficiency ratios could be used to measure how well Jafron Biomedical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Jafron Biomedical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 272.2 M, whereas Intangible Assets are forecasted to decline to about 53.5 M.

Technical Drivers

As of the 30th of November, Jafron Biomedical retains the Market Risk Adjusted Performance of 1.27, risk adjusted performance of 0.0777, and Downside Deviation of 2.77. Jafron Biomedical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Jafron Biomedical Price Movement Analysis

Jafron Biomedical Outstanding Bonds

Jafron Biomedical Predictive Daily Indicators

Jafron Biomedical Forecast Models

Jafron Biomedical's time-series forecasting models are one of many Jafron Biomedical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Jafron Biomedical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Jafron Biomedical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Jafron shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Jafron Biomedical. By using and applying Jafron Stock analysis, traders can create a robust methodology for identifying Jafron entry and exit points for their positions.

When running Jafron Biomedical's price analysis, check to measure Jafron Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jafron Biomedical is operating at the current time. Most of Jafron Biomedical's value examination focuses on studying past and present price action to predict the probability of Jafron Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jafron Biomedical's price. Additionally, you may evaluate how the addition of Jafron Biomedical to your portfolios can decrease your overall portfolio volatility.